Researchers recently synthesized phytogenic molybdenum nanoparticles using the leaf extract of Pterocarpus santalinus. Because this tree is native to India, it offers an accessible resource for green synthesis. This specific method utilizes the plant's natural compounds as reducing and stabilizing agents. Consequently, the resulting nanoparticles exhibit high purity and a distinct crystalline structure. Furthermore, the study confirms that these particles possess significant antioxidant and antimicrobial properties. Therefore, these findings provide valuable insights for clinicians and pharmaceutical researchers.

Characterization and Structural Insights

In terms of characterization, FE-SEM and EDAX revealed spherical nanoparticles with an average size of 35.71 nm. Additionally, XRD patterns confirmed an orthorhombic crystalline phase. Similarly, researchers identified specific functional groups through FT-IR. These biological groups are crucial for the capping and stabilization of the particles. Notably, the phytogenic approach avoids hazardous chemicals. Thus, it ensures a sustainable and eco-friendly production process. As a result, this method represents a significant advancement over traditional chemical reduction techniques.

Broad Efficacy of Phytogenic Molybdenum Nanoparticles

Regarding biological activity, the synthesized nanoparticles demonstrated an ABTS inhibition rate of 40.21% at 100 µg/mL. Specifically, this antioxidant capacity matches the performance of ascorbic acid. Moreover, the particles showed potent antimicrobial activity against several pathogens. For example, they effectively inhibited Staphylococcus aureus and Pseudomonas syringae. These results indicate that phytogenic molybdenum nanoparticles could serve as effective biocontrol agents in medical and environmental settings. Additionally, the study highlighted their role in agriculture. For instance, the nanoparticles increased nitrate reductase activity by 67% and chlorophyll content by 79% in tested crops.

Future Directions and Safety

However, while these results are promising, researchers emphasize the need for further safety evaluations. Consequently, we must understand the environmental impact and human biocompatibility before practical implementation. Nevertheless, this study provides a robust foundation for future applications. Therefore, Red Sandalwood-mediated synthesis could eventually revolutionize both nanomedicine and sustainable agriculture.

Frequently Asked Questions

What are phytogenic molybdenum nanoparticles?

These are molybdenum-based particles synthesized using plant extracts, such as Red Sandalwood, which act as natural reducing agents instead of toxic chemicals.

How do these nanoparticles benefit agriculture?

They act as nano-fertilizers by boosting nitrate reductase activity and chlorophyll content, which leads to better plant growth and higher biomass accumulation.

Are these nanoparticles effective against human pathogens?

Yes, the study observed significant antimicrobial activity against several bacteria, including Staphylococcus aureus, indicating potential use in clinical biocontrol.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Shaik B et al. Phytogenic molybdenum nanoparticles using Pterocarpus santalinus: characterisation, antioxidant, antimicrobial, seed priming and nitrogen fixation activities. Sci Rep. 2026 May 11. doi: 10.1038/s41598-026-52544-1. PMID: 42115762.


2. Salim A & Sadhasivam S. Biofabricated MoO3 nanoparticles for biomedical applications: Antibacterial efficacy, hemocompatibility, and wound healing properties. Nano and Medical Materials. 2023;3(1). doi: 10.59400/nmm.v3i1.73.


3. Bharathidasan P et al. Green Synthesis of Molybdenum Nanoparticles From Solanum xanthocarpum and Evaluation of Their Antimicrobial and Antioxidant Activity Against Multidrug-Resistant Wound Isolates. Cureus. 2022;14(10):e30345. doi: 10.7759/cureus.30345.